Evidence map›Paper›PMID 40434050›Full record

ArticleACS applied materials & interfaces2025

Remote Control of Gold-Iron Nanowires Using Low-Frequency 1 Hz Magneto-Mechanical Therapy and Cesium 137 0.662 MeV Radiotherapy for Treatment of Glioblastoma Multiforme.

Jonathan Taylor, George Greaves, Chris Clement Phillips, Matthew Williams, Mary P Ryan, Alexandra E Porter

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jonathan TaylorDepartment of Materials and London Centre for Nanotechnology, Imperial College, London SW7 2AZ, U.K.
George GreavesDepartment of Physics, Imperial College London, London SW72AZ, U.K.
Chris Clement PhillipsDepartment of Physics, Imperial College London, London SW72AZ, U.K.
Matthew WilliamsImperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Rd, London W6 8RF, U.K.
Mary P RyanDepartment of Materials and London Centre for Nanotechnology, Imperial College, London SW7 2AZ, U.K.ORCID 0000-0001-8582-3003
Alexandra E PorterDepartment of Materials and London Centre for Nanotechnology, Imperial College, London SW7 2AZ, U.K.ORCID 0000-0003-1295-105X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma (GBM) is an extremely infiltrative brain cancer that is impossible to fully remove surgically and almost always recurs at the borders of the resection cavity. There is increasing focus on inducing cancer cell death using magneto-mechanical therapy (MMT), which involves energy conversion of an external low-frequency magnetic field into mechanical forces using magnetic nanoparticles. Here, we combined MMT with enhanced radiotherapy (RT)─the standard of care treatment for GBM─to increase the efficiency of treatment using gold-iron nanowires (AuFe NWs). The magnetic iron component of the nanowires mechanically rotates, inducing cellular damage, and the gold scatters X-rays due to its high atomic number, enhancing the local RT dose. We show that reproducible synthesis of AuFe NWs with different ratios of gold:iron can be achieved using a hard-template electrochemical method, controlling composition by tuning the deposition current. Ratios with best-performing iron percentages were selected for computational modeling to predict which frequency should be applied

Indexed as

Brain NeoplasmsGlioblastomaGoldIronNanowiresCell Line, TumorCell SurvivalHumansGoldIronelectrochemical depositionglioblastoma multiformegold−iron nanowiremagneto-mechanical therapyradiotherapy

Identifiers

PMID40434050
PMCPMC12163923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.